Medicina
Departament
Eli Lilly and Company
Indianapolis, EE. UU.Publicacions en col·laboració amb investigadors/es de Eli Lilly and Company (15)
2024
2022
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2021
-
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
Diabetes Therapy, Vol. 12, Núm. 6, pp. 1631-1659
2016
-
A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement
European Geriatric Medicine, Vol. 7, Núm. 6, pp. 519-525
2012
-
Delphi consensus on the physical health of patients with schizophrenia: Evaluation of the recommendations of the Spanish societies of psychiatry and biological psychiatry by a panel of experts
Actas Espanolas de Psiquiatria, Vol. 40, Núm. 3, pp. 114-128
2011
-
Clinical meaningful outcomes in schizophrenia: Remission and recovery
Revista de Psiquiatria y Salud Mental, Vol. 4, Núm. 1, pp. 53-65
2009
-
Pemetrexed in first-line treatment of non-small cell lung cancer
Cancer Treatment Reviews, Vol. 35, Núm. 4, pp. 364-373
2007
-
Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
Annals of Oncology, Vol. 18, Núm. 8, pp. 1359-1362
-
Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study
European Psychiatry, Vol. 22, Núm. 8, pp. 490-498
2005
-
Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, Núm. 6, pp. 944-951
-
Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: A multivariate analysis of a large naturalistic study in the hospital setting
Medicina Clinica, Vol. 124, Núm. 13, pp. 481-486
2004
-
Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761
2003
-
Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Núm. 3, pp. 473-481
-
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study
European Neuropsychopharmacology, Vol. 13, Núm. 1, pp. 39-48
2002
-
Características de la versión española del cuestionario de calidad de vida QLSM-H en sujetos adultos con deficiencia de hormona de crecimiento tratados con somatotropina. Estudio piloto
Endocrinologia y Nutricion, Vol. 49, Núm. 4, pp. 105-112